| Improving blood pressure control through pharmacist interventions: a meta‐analysis of randomized controlled trials V Santschi, A Chiolero, AL Colosimo, RW Platt, P Taffé, M Burnier, ... Journal of the American Heart Association 3 (2), e000718, 2014 | 407 | 2014 |
| Gilbert syndrome and the development of antiretroviral therapy–associated hyperbilirubinemia M Rotger, P Taffé, G Bleiber, HF Günthard, H Furrer, P Vernazza, ... The Journal of infectious diseases 192 (8), 1381-1386, 2005 | 263 | 2005 |
| Ageing with HIV: medication use and risk for potential drug–drug interactions C Marzolini, D Back, R Weber, H Furrer, M Cavassini, A Calmy, ... Journal of antimicrobial chemotherapy 66 (9), 2107-2111, 2011 | 237 | 2011 |
| Polymorphisms in Toll-like receptor 9 influence the clinical course of HIV-1 infection PY Bochud, M Hersberger, P Taffé, M Bochud, CM Stein, SD Rodrigues, ... Aids 21 (4), 441-446, 2007 | 221 | 2007 |
| Undertreatment of acute pain (oligoanalgesia) and medical practice variation in prehospital analgesia of adult trauma patients: a 10 yr retrospective study E Albrecht, P Taffe, B Yersin, P Schoettker, I Decosterd, O Hugli British journal of anaesthesia 110 (1), 96-106, 2013 | 208 | 2013 |
| Molecular epidemiology reveals long-term changes in HIV type 1 subtype B transmission in Switzerland RD Kouyos, V Von Wyl, S Yerly, J Böni, P Taffé, C Shah, P Börgisser, ... The Journal of infectious diseases 201 (10), 1488-1497, 2010 | 201 | 2010 |
| Ambiguous nucleotide calls from population-based sequencing of HIV-1 are a marker for viral diversity and the age of infection RD Kouyos, V von Wyl, S Yerly, J Böni, P Rieder, B Joos, P Taffé, C Shah, ... Clinical infectious diseases 52 (4), 532-539, 2011 | 172 | 2011 |
| Sodium intake and blood pressure in children and adolescents: a systematic review and meta-analysis of experimental and observational studies M Leyvraz, A Chatelan, BR da Costa, P Taffe, G Paradis, P Bovet, ... International journal of epidemiology 47 (6), 1796-1810, 2018 | 170 | 2018 |
| High prevalence of peripheral arterial disease in HIV-infected persons D Periard, M Cavassini, P Taffé, M Chevalley, L Senn, C Chapuis-Taillard, ... Clinical infectious diseases 46 (5), 761-767, 2008 | 165 | 2008 |
| Modeling the Influence of APOC3, APOE and TNF Polymorphisms on the Risk of Antiretroviral Therapy–Associated Lipid Disorders PE Tarr, P Taffé, G Bleiber, H Furrer, M Rotger, R Martinez, B Hirschel, ... The Journal of infectious diseases 191 (9), 1419-1426, 2005 | 153 | 2005 |
| Role of retroviral restriction factors in the interferon-α–mediated suppression of HIV-1 in vivo SK Pillai, M Abdel-Mohsen, J Guatelli, M Skasko, A Monto, K Fujimoto, ... Proceedings of the National Academy of Sciences 109 (8), 3035-3040, 2012 | 144 | 2012 |
| Rate of undesirable events at beginning of academic year: retrospective cohort study G Haller, PS Myles, P Taffé, TV Perneger, CL Wu Bmj 339, 2009 | 144 | 2009 |
| All cause mortality in the Swiss HIV Cohort Study from 1990 to 2001 in comparison with the Swiss population O Keiser, P Taffé, M Zwahlen, M Battegay, E Bernasconi, R Weber, ... Aids 18 (13), 1835-1843, 2004 | 139 | 2004 |
| Contribution of 20 single nucleotide polymorphisms of 13 genes to dyslipidemia associated with antiretroviral therapy M Arnedo, P Taffé, R Sahli, H Furrer, B Hirschel, L Elzi, R Weber, ... Pharmacogenetics and genomics 17 (9), 755-764, 2007 | 107 | 2007 |
| Hepatitis B virus infection is associated with impaired immunological recovery during antiretroviral therapy in the Swiss HIV cohort study G Wandeler, T Gsponer, F Bihl, E Bernasconi, M Cavassini, H Kovari, ... The Journal of infectious diseases 208 (9), 1454-1458, 2013 | 102 | 2013 |
| Treatment-naive individuals are the major source of transmitted HIV-1 drug resistance in men who have sex with men in the Swiss HIV Cohort Study SM Drescher, V von Wyl, WL Yang, J Böni, S Yerly, C Shah, V Aubert, ... Clinical Infectious Diseases 58 (2), 285-294, 2014 | 100 | 2014 |
| How much protein and energy are needed to equilibrate nitrogen and energy balances in ventilated critically ill children? CJ Chaparro, JL Depeyre, D Longchamp, MH Perez, P Taffé, J Cotting Clinical nutrition 35 (2), 460-467, 2016 | 96 | 2016 |
| In vitro whole-genome analysis identifies a susceptibility locus for HIV-1 C Loeuillet, S Deutsch, A Ciuffi, D Robyr, P Taffe, M Munoz, JS Beckmann, ... PLoS biology 6 (2), e32, 2008 | 84 | 2008 |
| Polymorphisms of the endothelin-1 gene associate with hypertension in patients with rheumatoid arthritis VF Panoulas, KMJ Douglas, JP Smith, P Taffé, A Stavropoulos-Kalinoglou, ... Endothelium 15 (4), 203-212, 2008 | 80 | 2008 |
| Mandatory infectious diseases consultation for MRSA bacteremia is associated with reduced mortality F Tissot, T Calandra, G Prod'Hom, P Taffe, G Zanetti, G Greub, L Senn Journal of Infection 69 (3), 226-234, 2014 | 79 | 2014 |